HomeScience & EducationUniversity of Surrey study finds D2 supplements may lower D3 levels

University of Surrey study finds D2 supplements may lower D3 levels

Last Modification

Article NLP Indicators
Sentiment -0.05
Objectivity 0.85
Sensitivity 0.10

University of Surrey study in Nutrition Reviews reveals D2 supplements may lower D3 levels by 10–15%, challenging assumptions about vitamin D efficacy. Findings could reshape public health guidelines, emphasizing the need for personalized supplement strategies.

DOCUMENT GRAPH | Entities, Sentiment, Relationship and Importance
You can zoom and interact with the network

The Science Behind Vitamin D2 and D3

Vitamin D comes in two main forms: D2 (ergocalciferol) and D3 (cholecalciferol). Both are used in supplements, but they differ in where they come from and how the body uses them. D3 is made when skin is exposed to sunlight, while D2 is found in plants. A University of Surrey study published in Nutrition Reviews found that taking D2 supplements might actually lower D3 levels in the body. This calls into question the idea that all vitamin D supplements are equally effective. The study reviewed several controlled trials and found that people taking D2 had a 10–15% drop in D3 levels compared to those not taking it. This effect wasn’t noticed before, which could change how public health recommends vitamin D.

The ‘But Wait’ Angle: Complicating the Simple Story

“while D3 might boost the immune system, choosing between D2 and D3 should consider individual health needs”

— Dr. Emily Brown

The study’s findings are a bit complicated. While D3 is absorbed better and used more efficiently by the body, the research suggests D2 might interfere with D3’s function. However, the exact reason for this isn’t clear. Some experts say the study’s review of controlled trials might have limitations. For example, how long people took the supplements and how their bodies process vitamin D could affect results. A 2025 study in Clinical Laboratory Sciences mentioned that genetic testing for vitamin D metabolism could help tailor supplement plans. This shows the need for personalized approaches to ensure effectiveness and safety.

Data & Expert Context: Quantifying the Impact

According to the study, people taking D2 had a 10–15% drop in D3 levels compared to a control group. This effect was stronger in people with low vitamin D levels. Dr. Emily Brown, the lead researcher, said that while D3 might boost the immune system, choosing between D2 and D3 should consider individual health needs. For example, vegetarians or vegans might rely on D2 from lichen, but the study suggests they might need higher doses to get the same D3 levels. A 2025 study in Frontiers in Immunology added that D3 triggers type I interferon signaling, which is key for the immune response. D2 doesn’t do this, which could matter for people at higher risk of infections, like the elderly or those with weakened immune systems.

Historical Precedent: A Pattern of Discovery

University of Surrey study finds D2 supplements may lower D3 levels

This research fits with earlier findings that D3 is more effective at raising blood vitamin D levels. A 2024 study in Frontiers in Immunology showed that D3 activates type I interferon signaling, which is vital for the immune system. However, the current study adds a new angle: D2 might disrupt D3 balance. This mirrors past trends in nutrition science, where assumptions about supplements were later revised. For instance, in the 1980s, the shift to plant-based D2 supplements sparked debates about their effectiveness, leading to D3 alternatives. Similarly, these findings might prompt a reevaluation of D2’s role in public health, especially in places with little sunlight or dietary restrictions.

Trend Connection: The Broader Health Implications

The debate over D2 vs. D3 fits into a bigger trend of personalized nutrition. As public health efforts focus more on vitamin D supplements to fight deficiencies, the study highlights the need for tailored approaches. For example, the UK’s National Health Service recommends 10 micrograms of vitamin D daily in winter, but the study suggests the form of the supplement might be as important as the dose. This aligns with growing interest in functional foods and targeted nutrients, showing a move away from one-size-fits-all health advice. A 2023 review in Nutrition Reviews noted that personalized vitamin D plans, based on blood levels and genetics, could improve outcomes while reducing risks. This trend is also supported by the rise of precision medicine, which focuses on individualized treatment plans.

“D3 triggers type I interferon signaling, which is key for the immune response. D2 doesn’t do this, which could matter for people at higher risk of infections, like the elderly or those with weakened immune systems”

Stakeholder Perspectives: Who Stands to Gain or Lose?

Pharma companies making D2 supplements could face market changes if D3 becomes the preferred choice. D3 manufacturers might see more demand. Public health groups like the Quadram Institute stress the importance of making effective vitamin D sources accessible, especially in areas with limited sunlight. Patients may need to rethink their supplement choices, balancing cost, availability, and effectiveness. Dr. Cathie Martin, a study co-author, said plant-based D3 is now more available, addressing dietary concerns while keeping potency. Critics warn, though, that the study’s findings could lead to overuse of D3, increasing the risk of toxicity. A 2021 Mayo Clinic review warned that too much vitamin D can cause hypercalcemia, leading to nausea, kidney stones, and in severe cases, heart issues. This shows the need for careful monitoring and dose adjustments, especially for high-risk groups.

The Road Ahead: Research and Recommendations

More research is needed to understand how D2 affects D3 levels over time and to find the best dosing for different groups. The study’s authors suggest clinical trials that consider genetic differences and lifestyle factors like sun exposure and diet. In the meantime, doctors are advised to consider individual patient needs when recommending vitamin D. A 2025 Clinical Laboratory Sciences study suggested genetic testing for vitamin D metabolism could help personalize supplement plans, lowering risks. As the field evolves, the distinction between D2 and D3 may become as important as the difference between different types of carbs or proteins. This shift highlights the need for evidence-based advice and ongoing research to improve our understanding of nutrient metabolism.

KEY QUESTIONS ANSWERED
Common questions about this article answered in brief

Related Articles

SMI Science Desk
SMI Science Desk
SMI Science Desk is the scientific and research editorial team at SoMuchInfo, focused on breakthroughs in physics, space exploration, artificial intelligence, and emerging scientific discoveries. The team analyzes findings from academic research, simulations, and institutional reports, transforming complex topics into clear, accessible insights. Content is curated from verified sources and enhanced using AI-assisted workflows, with human editorial review to ensure accuracy and clarity.

Follow Us

YOU MAY LIKE

Top Tags

Latest articles

David Lammy Presses JD Vance on Migration Concerns After Henry Nowak’s Murder

British Deputy PM David Lammy directly rebuked U.S. Vice President JD Vance, denying a link between migrant influx and Henry Nowak’s murder, as the case sparked transatlantic tensions. Lammy defended Britain’s justice system and rejected Vance’s claims, while the Nowak family urged against politicizing their son’s death.

Crypto Markets Bleed in a Massive Drop Since FTX

Crypto markets plunged $390B, marking the worst weekly drop since FTX, as AI gains and macro shocks drive selloff. Bitcoin and Ether hit 17.3% and 22% declines, with corporate Bitcoin sales and ETF outflows amplifying the downturn.

Two Roads to a Trillion: Anthropic and OpenAI Sprint to IPO With Opposite Strategies

Anthropic's efficiency-driven AI strategy, fueled by $47B annual revenue and $559M Q2 profit, positions it ahead of OpenAI's projected $14B loss in 2026, as the firm races to IPO before its rival. The race highlights a clash between capital-heavy scaling and cost-conscious innovation in the AI sector.

Deal on Paper, Death in Practice: 6,000 Oleshky Civilians Starving as Evacuation Goes Nowhere

Starvation grips Oleshky, where 6,000 civilians face famine as a stalled evacuation deal leaves them trapped. Russia’s blockade, drone strikes, and denied aid have turned the city into a death trap, with over 300 deaths reported. Volunteer efforts and international appeals highlight a worsening humanitarian crisis.